Keira Fines
Good Clinical Practice Compliance Manager for Clinical Research
I am the OCTRU Good Clinical Practice Compliance Manager for Clinical Research, working within the Quality Assurance team where I help ensure compliance is maintained and continued process improvement is progressed across the unit.
I am passionate about ensuring trials are carried out to the highest standards with patient safety and data integrity being paramount.
Prior to joining OCTRU, I worked for over 6 years at the Southampton Clinical Trials Unit. Joining in 2016 as a Trials Assistant, moving into the Quality and Regulatory Team in 2017 and then progressing to holding the position of Pharmacovigilance Manager for over 2 years.
I achieved a BSc with First Class Honours in Psychology from Oxford Brookes University in 2011.
Recent publications
-
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
Walker LE. et al, (2022), Clin pharmacol ther, 111, 585 - 594
-
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
Khoo SH. et al, (2021), J antimicrob chemother, 76, 3286 - 3295
-
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.
Lim SH. et al, (2018), Trials, 19